To access this element change to forms mode OFF
Grant Award View - GA217905
HEPATA: Hereditary Pancreatitis and AutoIslet Transplant Trials in...
GA ID:
GA217905
Agency:
Department of Health and Aged Care
Approval Date:
6-Dec-2021
Publish Date:
16-Feb-2022
Category:
Health and Medical Research
Grant Term:
1-Feb-2022 to 31-Jan-2027
Value (AUD):
$2,014,561.20
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
HEPATA: Hereditary Pancreatitis and AutoIslet Transplant Trials in Australia
Purpose:
The aim of this project is to collect the evidence required for TP-IAT to become a reimbursed medical procedure for the treatment of hereditary pancretitis (HP). In order to achieve this 24 HP patients will undergo TP-IAT and the impact on disease progression, quality of life, reduction in pain medication, hospitalisations, health costs and economic impacts will be determined. This will allow a formal application to the goverment for assesment of TP-IAT to become a reimbursed medical procedure.
GO ID:
GO Title:
MRFF 2021 Rare Cancers Rare Diseases Unmet Need General - Grant Opportunity
Internal Reference ID:
2021/MRF2014872
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The University of Adelaide
Recipient ABN:
61 249 878 937
Grant Recipient Location
Suburb:
Adelaide
Town/City:
Adelaide
Postcode:
5000
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, SA
Postcode:
Multiple
Country:
AUSTRALIA